| Chair | Polly E. Parsons, MD, ATSF | Williston, VT |
| Committee Member | Alana Clemens - Saliba | Bridgewater, NJ |
| Committee Member | Basak Coruh, MD, MSc, ATSF, FCCP | Seattle, WA |
| Committee Member | Charles C. Hardin, MD, PhD, ATSF | Boston, MA |
| Committee Member | Charlotte Summers, MBBS, PhD | Cambridge, CAMBS, United Kingdom |
| Committee Member | Christopher F. Chesley, MD, MSCE | Philadelphia, PA |
| Committee Member | Dona J. Upson, MD, MA, ATSF | Albuquerque, NM |
| Committee Member | Erick Forno, MD, MPH, ATSF | Indianapolis, IN |
| Committee Member | Heidi M. Mansour, PhD, RPh | Port St. Lucie, FL |
| Committee Member | Isaretta L. Riley, MD, MPH | Durham, NC |
| Committee Member | James K. O'Brien, MD | Denver, CO |
| Committee Member | Jess Mandel, MD, FRCP, FACP, ATSF | La Jolla, CA |
| Committee Member | Kathleen O. Lindell, PhD, RN, ATSF | Charleston, SC |
| Committee Member | Sakshi Dua, MBBS, ATSF | New York, NY |
| Committee Member | Samya Z. Nasr, MD, ATSF | Ann Arbor, MI |
| Committee Member | Stuart C. Sweet, MD, PhD | Saint Louis, MO |
| Committee Member | Susan Sherman, BS, MHA | Cincinnati, OH |
| Staff | Diane Gern | New York, NY |
| Staff | Rachel Kaye |
1) Determine if ATS 2026, 2032, 2034 (Orlando) and ATS 2027 (New Orleans) should proceed as currently contracted;
2) Recommend seeking input from the ATS Ethics and Conflict of Interest Committee (ECOI) to define which cities would be deemed unacceptable for the International Conference given the safety concerns of all of our members;
3) Based on the above and available information and best prediction,
a) explore the feasibility of pulling out of established contracts with special attention to logistics, whether other cities are available, costs and other potential liabilities, etc. (see list of considerations below) and
b) make recommendation to Board of Directors that clearly explains the consequences of canceling meetings without other options or alternative sources of revenue (by the end of August);
4) Longer term tasks--collaborate with the International Conference (IC) and Health Policy Committees to explore:
a) changes in meeting format to accommodate the need (e.g., meeting size, hybrid option, etc.) going forward, etc.
b) opportunities to advocate for desired changes in offensive state laws
